Diadema Partners LP Portfolio Holdings

Diadema Partners LP

  • $328 Billion
  • Q2 2025

Diadema Partners LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $328 Billion distributed in 96 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Soleno Therapeutics Inc with a value of $23.8B, Amgen Inc with a value of $14.5B, Tg Therapeutics, Inc. with a value of $13.4B, Neurocrine Biosciences Inc with a value of $11.8B, and Eli Lilly & CO with a value of $11.5B.

Examining the 13F form we can see an decrease of $55.1B in the current position value, from $383B to 328B.

Diadema Partners LP is based out at Morristown, NJ

Below you can find more details about Diadema Partners LP portfolio as well as his latest detailed transactions.

Portfolio value $328 Billion
Healthcare: $283 Billion
ETFs: $8.29 Billion

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$9.2M
$1.04 Billion 0.32% of portfolio
2,735,457
Q2 2025 Added 320.37%
$36.6M
$175 Million 0.05% of portfolio
64,613
Q1 2025 Reduced 14.75%
$8.39M
$133 Million 0.04% of portfolio
362,935
Q2 2025 New

Summary

  • Portfolio
  • No. of Stocks 96
  • Current Value $328 Billion
  • Prior Value $383 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 17 stocks
  • Additional Purchases 16 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 11 stocks
Track This Portfolio

Track Diadema Partners LP Portfolio

Follow Diadema Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Diadema Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Diadema Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email